Template:Methyldopa: Difference between revisions

Revision as of 04:19, 10 March 2014

Methyldopa
METHYLDOPA tablet^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
METHYLDOPA injection^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Methyldopa
ClinicalTrials.gov

@@ Line 12: / Line 12: @@
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Methyldopa tablet contraindications|Contraindications]]
 |-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Methyldopa tablet warnings and precautions|Warnings and Precautions]]
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Methyldopa tablet warnings|Warnings]]
+|-
+! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Methyldopa tablet precautions|Precautions]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Methyldopa tablet adverse reactions|Adverse Reactions]]